skip to main content
Language:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters

Results 1 - 20 of 30  for All Library Resources

Results 1 2 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Gastrointestinal dysfunction in Parkinson’s disease: molecular pathology and implications of gut microbiome, probiotics, and fecal microbiota transplantation
Material Type:
Article
Add to My Research

Gastrointestinal dysfunction in Parkinson’s disease: molecular pathology and implications of gut microbiome, probiotics, and fecal microbiota transplantation

Journal of neurology, 2022-03, Vol.269 (3), p.1154-1163 [Peer Reviewed Journal]

Crown 2021 ;2021. Crown. ;Crown 2021. ;ISSN: 0340-5354 ;EISSN: 1432-1459 ;DOI: 10.1007/s00415-021-10567-w ;PMID: 33881598

Full text available

2
Parkinson's disease sleep scale-validation of the revised version PDSS-2
Material Type:
Article
Add to My Research

Parkinson's disease sleep scale-validation of the revised version PDSS-2

Movement disorders, 2011-03, Vol.26 (4), p.644-652 [Peer Reviewed Journal]

Copyright © 2011 Movement Disorder Society ;Copyright © 2011 Movement Disorder Society. ;ISSN: 0885-3185 ;EISSN: 1531-8257 ;DOI: 10.1002/mds.23476 ;PMID: 21312275 ;CODEN: MOVDEA

Full text available

3
Safety and tolerability of long-term apomorphine infusion in advanced Parkinson's disease: an Indian multi-center (APO-IND) experience
Material Type:
Article
Add to My Research

Safety and tolerability of long-term apomorphine infusion in advanced Parkinson's disease: an Indian multi-center (APO-IND) experience

Scientific reports, 2023-10, Vol.13 (1), p.18681-18681, Article 18681 [Peer Reviewed Journal]

Crown 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Crown 2023 ;ISSN: 2045-2322 ;EISSN: 2045-2322 ;DOI: 10.1038/s41598-023-46003-4 ;PMID: 37907679

Full text available

4
Cross-sectional analysis of the Parkinson's disease Non-motor International Longitudinal Study baseline non-motor characteristics, geographical distribution and impact on quality of life
Material Type:
Article
Add to My Research

Cross-sectional analysis of the Parkinson's disease Non-motor International Longitudinal Study baseline non-motor characteristics, geographical distribution and impact on quality of life

Scientific reports, 2021-05, Vol.11 (1), p.9611-9611, Article 9611 [Peer Reviewed Journal]

The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 2045-2322 ;EISSN: 2045-2322 ;DOI: 10.1038/s41598-021-88651-4 ;PMID: 33953218

Full text available

5
WED 270 Optician’s diagnosis of papilloedema impact hospital admissions
Material Type:
Article
Add to My Research

WED 270 Optician’s diagnosis of papilloedema impact hospital admissions

Journal of neurology, neurosurgery and psychiatry, 2018-10, Vol.89 (10), p.A39-A39 [Peer Reviewed Journal]

2018, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;2018 2018, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;ISSN: 0022-3050 ;EISSN: 1468-330X ;DOI: 10.1136/jnnp-2018-ABN.136

Full text available

6
WED 014 Oct minimises unnecessary investigation for suspected papilloedema
Material Type:
Article
Add to My Research

WED 014 Oct minimises unnecessary investigation for suspected papilloedema

Journal of neurology, neurosurgery and psychiatry, 2018-10, Vol.89 (10), p.A3-A3 [Peer Reviewed Journal]

2018, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;2018 2018, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions ;ISSN: 0022-3050 ;EISSN: 1468-330X ;DOI: 10.1136/jnnp-2018-ABN.9

Full text available

7
Chaudhuri's Dashboard of Vitals in Parkinson's syndrome: an unmet need underpinned by real life clinical tests
Material Type:
Article
Add to My Research

Chaudhuri's Dashboard of Vitals in Parkinson's syndrome: an unmet need underpinned by real life clinical tests

Frontiers in neurology, 2023-05, Vol.14, p.1174698-1174698 [Peer Reviewed Journal]

Copyright © 2023 Qamar, Rota, Batzu, Subramanian, Falup-Pecurariu, Titova, Metta, Murasan, Odin, Padmakumar, Kukkle, Borgohain, Kandadai, Goyal and Ray Chaudhuri. ;Copyright © 2023 Qamar, Rota, Batzu, Subramanian, Falup-Pecurariu, Titova, Metta, Murasan, Odin, Padmakumar, Kukkle, Borgohain, Kandadai, Goyal and Ray Chaudhuri. 2023 Qamar, Rota, Batzu, Subramanian, Falup-Pecurariu, Titova, Metta, Murasan, Odin, Padmakumar, Kukkle, Borgohain, Kandadai, Goyal and Ray Chaudhuri ;ISSN: 1664-2295 ;EISSN: 1664-2295 ;DOI: 10.3389/fneur.2023.1174698 ;PMID: 37305739

Full text available

8
Real‐life benefits of intrajejunal levodopa infusion therapy in four patients with the parkinsonian variant of progressive supranuclear palsy: A 1‐year follow‐up data report
Material Type:
Article
Add to My Research

Real‐life benefits of intrajejunal levodopa infusion therapy in four patients with the parkinsonian variant of progressive supranuclear palsy: A 1‐year follow‐up data report

Brain and behavior, 2022-09, Vol.12 (9), p.e2547-n/a [Peer Reviewed Journal]

2022 The Authors. published by Wiley Periodicals LLC. ;2022 The Authors. Brain and Behavior published by Wiley Periodicals LLC. ;2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2162-3279 ;EISSN: 2162-3279 ;DOI: 10.1002/brb3.2547 ;PMID: 35943202

Full text available

9
Personalised Advanced Therapies in Parkinson’s Disease: The Role of Non-Motor Symptoms Profile
Material Type:
Article
Add to My Research

Personalised Advanced Therapies in Parkinson’s Disease: The Role of Non-Motor Symptoms Profile

Journal of personalized medicine, 2021-08, Vol.11 (8), p.773 [Peer Reviewed Journal]

2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 2075-4426 ;EISSN: 2075-4426 ;DOI: 10.3390/jpm11080773 ;PMID: 34442417

Full text available

10
Hiccups, Hypersalivation, Hallucinations in Parkinson's Disease: New Insights, Mechanisms, Pathophysiology, and Management
Material Type:
Article
Add to My Research

Hiccups, Hypersalivation, Hallucinations in Parkinson's Disease: New Insights, Mechanisms, Pathophysiology, and Management

Journal of personalized medicine, 2023-04, Vol.13 (5), p.711 [Peer Reviewed Journal]

2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2023 by the authors. 2023 ;ISSN: 2075-4426 ;EISSN: 2075-4426 ;DOI: 10.3390/jpm13050711 ;PMID: 37240881

Full text available

11
Parkinson’s Disease: Personalized Pathway of Care for Device-Aided Therapies (DAT) and the Role of Continuous Objective Monitoring (COM) Using Wearable Sensors
Material Type:
Article
Add to My Research

Parkinson’s Disease: Personalized Pathway of Care for Device-Aided Therapies (DAT) and the Role of Continuous Objective Monitoring (COM) Using Wearable Sensors

Journal of personalized medicine, 2021-07, Vol.11 (7), p.680 [Peer Reviewed Journal]

2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 by the authors. 2021 ;ISSN: 2075-4426 ;EISSN: 2075-4426 ;DOI: 10.3390/jpm11070680 ;PMID: 34357147

Full text available

12
Subcutaneous apomorphine in advanced Parkinson’s disease and its use in Indian population
Material Type:
Article
Add to My Research

Subcutaneous apomorphine in advanced Parkinson’s disease and its use in Indian population

Annals of movement disorders, 2020-09, Vol.3 (3), p.145-155 [Peer Reviewed Journal]

ISSN: 2590-3446 ;EISSN: 2590-3454 ;DOI: 10.4103/AOMD.AOMD_16_20

Full text available

13
First Two-Year Observational Exploratory Real Life Clinical Phenotyping, and Societal Impact Study of Parkinson’s Disease in Emiratis and Expatriate Population of United Arab Emirates 2019–2021: The EmPark Study
Material Type:
Article
Add to My Research

First Two-Year Observational Exploratory Real Life Clinical Phenotyping, and Societal Impact Study of Parkinson’s Disease in Emiratis and Expatriate Population of United Arab Emirates 2019–2021: The EmPark Study

Journal of personalized medicine, 2022-08, Vol.12 (8), p.1300 [Peer Reviewed Journal]

2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 by the authors. 2022 ;ISSN: 2075-4426 ;EISSN: 2075-4426 ;DOI: 10.3390/jpm12081300 ;PMID: 36013249

Full text available

14
The Possible Clinical Predictors of Fatigue in Parkinson’s Disease: A Study of 135 Patients as Part of International Nonmotor Scale Validation Project
Material Type:
Article
Add to My Research

The Possible Clinical Predictors of Fatigue in Parkinson’s Disease: A Study of 135 Patients as Part of International Nonmotor Scale Validation Project

Parkinson's disease, 2011-01, Vol.2011, p.125271-7 [Peer Reviewed Journal]

Copyright © 2011 Antonio Strafella et al. ;Copyright © 2011 Vinod Metta et al. 2011 ;ISSN: 2042-0080 ;ISSN: 2090-8083 ;EISSN: 2042-0080 ;DOI: 10.4061/2011/125271 ;PMID: 22191065

Full text available

15
Fatigue in Parkinson’s disease is linked to striatal and limbic serotonergic dysfunction
Material Type:
Article
Add to My Research

Fatigue in Parkinson’s disease is linked to striatal and limbic serotonergic dysfunction

Brain (London, England : 1878), 2010-11, Vol.133 (11), p.3434-3443 [Peer Reviewed Journal]

2015 INIST-CNRS ;ISSN: 0006-8950 ;EISSN: 1460-2156 ;DOI: 10.1093/brain/awq268 ;PMID: 20884645

Full text available

16
Levodopa Dose Equivalency in Parkinson's Disease : Updated Systematic Review and Proposals
Material Type:
Article
Add to My Research

Levodopa Dose Equivalency in Parkinson's Disease : Updated Systematic Review and Proposals

Movement disorders, 2023-07, Vol.38 (7), p.1236 [Peer Reviewed Journal]

ISSN: 0885-3185 ;EISSN: 1531-8257 ;DOI: 10.1002/mds.29410

Digital Resources/Online E-Resources

17
Tolerability of overnight rotigotine transdermal patch combined with intrajejunal levodopa infusion at 1 year: a 24-h treatment option in Parkinson’s disease
Material Type:
Article
Add to My Research

Tolerability of overnight rotigotine transdermal patch combined with intrajejunal levodopa infusion at 1 year: a 24-h treatment option in Parkinson’s disease

Journal of Neural Transmission, 2022-07, Vol.129 (7), p.889-894 [Peer Reviewed Journal]

Crown 2022 ;ISSN: 0300-9564 ;EISSN: 1435-1463 ;DOI: 10.1007/s00702-022-02506-4

Digital Resources/Online E-Resources

18
The real-life effect of catechol-O-methyltransferase inhibition on non-motor symptoms in levodopa-treated Parkinson’s disease: opicapone versus entacapone
Material Type:
Article
Add to My Research

The real-life effect of catechol-O-methyltransferase inhibition on non-motor symptoms in levodopa-treated Parkinson’s disease: opicapone versus entacapone

Journal of Neural Transmission, 2023-07, Vol.130 (7), p.925-930 [Peer Reviewed Journal]

The Author(s) 2023 ;ISSN: 0300-9564 ;EISSN: 1435-1463 ;DOI: 10.1007/s00702-023-02603-y

Digital Resources/Online E-Resources

19
Exploring hyperhidrosis and related thermoregulatory symptoms as a possible clinical identifier for the dysautonomic subtype of Parkinson’s disease
Material Type:
Article
Add to My Research

Exploring hyperhidrosis and related thermoregulatory symptoms as a possible clinical identifier for the dysautonomic subtype of Parkinson’s disease

Journal of neurology, 2019-07, Vol.266 (7), p.1736-1742 [Peer Reviewed Journal]

The Author(s) 2019 ;Journal of Neurology is a copyright of Springer, (2019). All Rights Reserved. © 2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0340-5354 ;EISSN: 1432-1459 ;DOI: 10.1007/s00415-019-09325-w ;PMID: 30997572

Full text available

20
A 12-month prospective real-life study of opicapone efficacy and tolerability in Emirati and non-White subjects with Parkinson’s disease based in United Arab Emirates
Material Type:
Article
Add to My Research

A 12-month prospective real-life study of opicapone efficacy and tolerability in Emirati and non-White subjects with Parkinson’s disease based in United Arab Emirates

Journal of Neural Transmission, 2024-01, Vol.131 (1), p.25-30 [Peer Reviewed Journal]

Crown 2023 ;ISSN: 0300-9564 ;EISSN: 1435-1463 ;DOI: 10.1007/s00702-023-02700-y

Digital Resources/Online E-Resources

Results 1 - 20 of 30  for All Library Resources

Results 1 2 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (28)

Searching Remote Databases, Please Wait